科研平台

输血传染病研究中心围绕“降低输血传播疾病风险的技术和策略研究”这一主旨，与国内众多血液中心（中心血站），“一带一路”及“东盟”国家合作，具体开展如下相关研究（包括但不限于）。

Research in the Transfusion-transmitted Infectious Diseases Research Center aims to reduce the residual risk of transfusion-transmitted diseases by collaborating with domestic blood centers (central blood stations) and countries along the Belt and Road Initiative/ ASEAN. The following related research is performed (included but not limited to):

1.经血传播病原体的致病机制研究

包括病毒致病、免疫逃逸、耐药机制研究（含小分子RNA、外泌体、功能基因以及蛋白翻译后修饰等）。

1. Research on the mechanisms of transfusion-transmitted pathogens Includes viral pathogenesis, immune evasion, and drug resistance mechanisms (eg. small non-coding RNAs, exosomes, functional genes, and post-translational modifications).

2.符合中国国情的血液筛查策略研究

包括建立输血传播新发再发病原体的检测方法以及相关技术储备；不同地区的输血传播新发再发病原体的分子流行病学调查；不同地区的差异化血液筛查策略探究。

2.Research on Blood Screening Strategies Tailored to China's National Conditions

Aims to establish the detection methods for transfusion-transmitted emerging and re-emerging pathogens ; build related technical capabilities; perform epidemiological investigations of emerging and re-emerging pathogens potentially transmitted by blood transfusion in different regions; and explore differentiated blood screening strategies tailored to regional variations.

3.新型病毒灭活方法研究及第三方评价

包括新技术研发、病毒灭活效果验证方法的建立及对外服务等。

3. Research on the novel methods for virus inactivation and pathogen removal effectiveness validation platform

Including new technologies development and application in virus inactivation efficacy validation.

4.与“一带一路”及“东盟”国家在输血安全方面的合作

包括与这些国家的采供血机构开展科研合作，人才互访，人员培训等方面的合作，以期推广血液安全领域的“中国技术”与“中国方案”，提高输血研究所的国际影响力。

4. Cooperation with “Belt and Road” and ASEAN countries on blood  safety

Collaborate with blood collection and supply institutions of these countries in scientific research, personnel exchanges, and training programs, with the aim of promoting “Chinese technology” and “Chinese solutions” in blood safety and enhancing the international influence of our Institute.